---
schema_version: "secwatch.filing_event.v1"
accession: "0001438133-24-000026"
form_type: "8-K"
ticker: "TNDM"
cik: "0001438133"
company_name: "TANDEM DIABETES CARE INC"
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T21:55:50.798226+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Tandem Diabetes reports Q4/FY2023 results; detailed metrics not available in filing text

## Summary
- Press release furnished as Exhibit 99.1 contains financial results for quarter and year ended Dec 31, 2023.
- No specific figures (revenue, EPS, guidance) are included in the 8-K body or the provided excerpt.
- Investors should refer to the full press release for detailed financial data and management commentary.
- The filing is furnished under Item 2.02 and is not deemed filed for SEC purposes.

## SEC filing metadata
- accession: 0001438133-24-000026
- form_type: 8-K
- ticker: TNDM
- cik: 0001438133
- company_name: TANDEM DIABETES CARE INC
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438133/000143813324000026/0001438133-24-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438133/000143813324000026/tndm-20240221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001438133-24-000026
- JSON: https://secwatch.observer/filing/0001438133-24-000026.json
- Plain text: https://secwatch.observer/filing/0001438133-24-000026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.